In this episode of the Talking Biotech podcast, Kevin Folta and Dr. David Zaruk discuss the complexities surrounding glyphosate, particularly in light of the IARC Monograph 112 published a decade ago. They explore the implications of the reclassification of glyphosate as a probable carcinogen, the ensuing litigation, influence and corruption, and the ethical concerns regarding scientific integrity. The conversation delves into the role of the media, the influence of litigation finance, and the future of glyphosate in agriculture, emphasizing the need for transparency and evidence-based discussions over jury decisions.
Fler avsnitt av Talking Biotech with Dr. Kevin Folta
Visa alla avsnitt av Talking Biotech with Dr. Kevin FoltaTalking Biotech with Dr. Kevin Folta med Kevin Folta finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
